Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nature

• Publication date

  2001-10-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/35099568PMID 11607033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Butyrate sensitive suppressor of position-effect variegation mutations in drosophila melanogaster

  2004cited by this paper
• Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity

  2001cited by this paper
• Transcriptional dysregulation in Huntington's disease.

  2000cited by this paper
• Protein Aggregation and Pathogenesis of Huntingtons Disease: Mechanisms and Correlations

  2000cited by this paper
• CBP/p300 in cell growth, transformation, and development.

  2000cited by this paper
• The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

  2000cited by this paper
• Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.

  2000cited by this paper
• Identification of genes that modify ataxin-1-induced neurodegeneration

  2000cited by this paper
• Glutamine repeats and neurodegeneration.

  2000cited by this paper
• Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila.

  2000cited by this paper
• CREB-binding protein sequestration by expanded polyglutamine.

  2000cited by this paper
• Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.

  1999cited by this paper
• Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.

  1999cited by this paper
• Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold.

  1999cited by this paper
• p300 and CBP: Partners for life and death

  1999cited by this paper
• Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

  1998cited by this paper
• A rapid and sensitive assay for histone acetyl-transferase activity.

  1998cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• A genetic screen to identify components of the sina signaling pathway in Drosophila eye development.

  1998cited by this paper
• High level transactivation by a modified Bombyx ecdysone receptor in mammalian cells without exogenous retinoid X receptor.

  1998cited by this paper
• Huntingtin localization in brains of normal and Huntington's disease patients

  1997cited by this paper
• Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

  1996cited by this paper
• A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

  1996cited by this paper
• Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance.

  1994cited by this paper
• Distinct morphogenetic functions of similar small GTPases: Drosophila Drac1 is involved in axonal outgrowth and myoblast fusion.

  1994cited by this paper
• Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

  1993cited by this paper
• Information Processing in the Visual Systems of Arthropods

  1974cited by this paper
• Information Processing in the Visual Systems of Arthropods

  1973cited by this paper
• Pupil and Pseudopupil in the Compound Eye of Drosophila

  1972cited by this paper

• Identification of Drosophila melanogaster as a model organism in COPD research.

  2026cites this paper
• Contribution of neuroepigenetics to HD - developmental and aging-related signatures.

  2026cites this paper
• Daily intranasal resveratrol-conjugated gold nanoparticles administration promotes neuroprotection and improves neurological outcome in the R6/2 mouse model of Huntington's disease.

  2026cites this paper
• Landscape of Protein Post-Translational Modifications in Age-Related Neurodegenerative Disorders: Implications in Protein Aggregation, Altered Cellular Processes, and Therapeutics.

  2026cites this paper
• The advances in acetylation modification in senescence and aging-related diseases

  2025cites this paper
• Short-chain fatty acids in Huntington's disease: Mechanisms of action and their therapeutic implications.

  2025cites this paper
• Intersecting impact of CAG repeat and Huntingtin knockout in stem cell-derived cortical neurons

  2025cites this paper
• Modulating Cognition-Linked Histone Acetyltransferases (HATs) as a Therapeutic Strategy for Neurodegenerative Diseases: Recent Advances and Future Trends

  2025cites this paper
• The Promise of Epigenetic Editing for Treating Brain Disorders.

  2025cites this paper
• Mutant huntingtin induces neuronal apoptosis via derepressing the non-canonical poly(A) polymerase PAPD5

  2025influential citation
• ATRX: From Chromatin Remodeling to Disease

  2025cites this paper
• The Role of MicroRNAs in Neurodegeneration: Insights from Huntington’s Disease

  2025cites this paper
• Accelerated epigenetic aging in Huntington’s disease involves polycomb repressive complex 1

  2025cites this paper
• Histone hyperacetylation-linked upregulation of KRAB zinc finger proteins impedes glial differentiation in Huntington’s disease

  2025cites this paper
• Downregulation of Pten Improves Huntington’s Disease Phenotype by Reducing Htt Aggregates and Cell Death

  2025influential citation
• Intersecting impact of CAG repeat and huntingtin knockout in stem cell-derived cortical neurons

  2025cites this paper
• Therapeutic Potential of Sodium Butyrate in Neurological and Psychiatric Disorders

  2025cites this paper
• Inhibition of class IIa HDACs reduces mutant HTT aggregation by affecting RNA stability

  2025cites this paper
• Therapeutic Potential of Capsaicin in various Neurodegenerative Diseases with Special Focus on Nrf2 Signaling.

  2024cites this paper
• Protective role of Pten downregulation in Huntington’s Disease models

  2024cites this paper
• Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease models.

  2024cites this paper
• Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology

  2024cites this paper
• ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3

  2024cites this paper
• Neuroprotective Potential of Eugenol in Polyglutamine-Mediated Neurodegenerative Disease Using Transgenic Drosophila Model

  2024influential citation
• Epigenetics in rare neurological diseases

  2024cites this paper
• Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson’s disease

  2024cites this paper
• Advantages and differences among various animal models of Huntington’s disease

  2024cites this paper
• Unlocking the epigenetic symphony: histone acetylation's impact on neurobehavioral change in neurodegenerative disorders.

  2024cites this paper
• Gut Microbiota as a Modifier of Huntington’s Disease Pathogenesis

  2024cites this paper
• Exploring the versatility of Drosophila melanogaster as a model organism in biomedical research: a comprehensive review

  2024cites this paper
• Animal models in biomedical research: Relevance of Drosophila melanogaster

  2024cites this paper
• Plasticity of gene expression in the nervous system by exposure to environmental odorants that inhibit HDACs

  2024influential citation
• Polyglutamine disorders: Pathogenesis and potential drug interventions.

  2024cites this paper
• The Mendelian disorders of chromatin machinery: Harnessing metabolic pathways and therapies for treatment.

  2024cites this paper
• Retinal dysfunction in Huntington’s disease mouse models concurs with local gliosis and microglia activation

  2024cites this paper
• Increase in brain glycogen levels ameliorates Huntington's disease phenotype and rescues neurodegeneration in Drosophila

  2023cites this paper
• The Lysine Demethylase KDM7A Regulates Immediate Early Genes in Neurons

  2023cites this paper
• Modeling Huntington's disease: An insight on in-vitro and in-vivo models.

  2023cites this paper
• Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila.

  2023cites this paper
• Expanded polyQ aggregates interact with sarco-endoplasmic reticulum calcium ATPase and Drosophila inhibitor of apoptosis protein1 to regulate polyQ mediated neurodegeneration in Drosophila.

  2023cites this paper
• Decoding Neurodegeneration: A Comprehensive Review of Molecular Mechanisms, Genetic Influences, and Therapeutic Innovations

  2023cites this paper
• High-Contrast PET Imaging with [18F]NT160, a Class-IIa Histone Deacetylase Probe for In Vivo Imaging of Epigenetic Machinery in the Central Nervous System

  2023cites this paper
• The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ

  2023cites this paper
• The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases

  2023cites this paper
• Plasticity of gene expression in the nervous system by exposure to environmental odorants that inhibit HDACs

  2023cites this paper
• Juvenile and adult expression of polyglutamine expanded huntingtin produce distinct aggregate distributions in Drosophila muscle

  2023cites this paper
• Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration

  2023cites this paper
• Quantitation of Glutamine Synthetase 1 Activity in Drosophila melanogaster.

  2023cites this paper
• The Pleiotropic Face of CREB Family Transcription Factors

  2023cites this paper
• Polyglutamine disease in peripheral tissues.

  2023cites this paper
• Mutant huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure

  2023cites this paper
• Visualization of Mutant Aggregates from Clock Neurons by Agarose Gel Electrophoresis (AGERA) in Drosophila melanogaster.

  2022cites this paper
• The role of short-chain fatty acids in central nervous system diseases

  2022cites this paper
• Parkinson's Disease Is Associated with Impaired Gut–Blood Barrier for Short‐Chain Fatty Acids

  2022cites this paper
• Altered activity-regulated H3K9 acetylation at TGF-beta signaling genes during egocentric memory in Huntington's disease.

  2022cites this paper
• Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets

  2022cites this paper
• Gene Therapy, A potential Therapeutic Tool for Neurological and Neuropsychiatric Disorders: Applications, Challenges and Future Prospective.

  2022cites this paper
• Hsp40 overexpression in pacemaker neurons delays circadian dysfunction in a Drosophila model of Huntington's disease

  2022cites this paper
• Environmental stimulation in Huntington disease patients and animal models.

  2022cites this paper
• Progressive transcriptional changes in metabolic genes and altered fatbody homeostasis in Drosophila model of Huntington’s disease

  2022cites this paper
• The Role of H3K4me3 in Transcriptional Regulation Is Altered in The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease Huntington's Disease how document you.

  2022cites this paper
• MicroRNA editing patterns in Huntington’s disease

  2022cites this paper
• Polyglutamine-expanded ATXN7 alters a specific epigenetic signature underlying photoreceptor identity gene expression in SCA7 mouse retinopathy

  2022cites this paper
• Acetylation State of Lysine 14 of Histone H3.3 Affects Mutant Huntingtin Induced Pathogenesis

  2022cites this paper
• High-Contrast PET imaging with [18F]-NT160, a Class-IIa Histone Deacetylase (Class-IIa HDAC) Probe for In Vivo Imaging of Epigenetic Machinery in the Central Nervous System

  2022cites this paper
• Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics

  2022cites this paper
• Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases.

  2022cites this paper
• Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington’s disease

  2022cites this paper
• A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases

  2022cites this paper
• Hsc70-4 aggravates PolyQ-mediated neurodegeneration by modulating NF-κB mediated immune response in Drosophila

  2022cites this paper
• The current state of amyloidosis therapeutics and the potential role of fluorine in their treatment.

  2022cites this paper
• Epigenetic Regulation in Neurodegeneration Disease

  2022cites this paper
• Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma.

  2022cites this paper
• HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington’s disease pathogenesis

  2022cites this paper
• Protection of Phytoextracts against Rotenone-Induced Organismal Toxicities in Drosophila melanogaster via the Attenuation of ROS Generation

  2022cites this paper
• The CRTC-CREB axis functions as a transcriptional sensor to protect against proteotoxic stress in Drosophila

  2022influential citation
• Autosomal Dominant Spinocerebellar Ataxias and Episodic Ataxias

  2021cites this paper
• Histone deacetylase in neuropathology.

  2021cites this paper
• Genetic architecture of motor neuron diseases.

  2021cites this paper
• Pan-neuronal expression of human mutant huntingtin protein in Drosophila impairs immune response of hemocytes.

  2021cites this paper
• Management of altered metabolic activity in Drosophila model of Huntington’s disease by curcumin

  2021cites this paper
• Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington’s Disease Models

  2021influential citation
• Glial AP1 is activated with aging and accelerated by traumatic brain injury

  2021cites this paper
• Fluorescent molecular probe-based activity and inhibition monitoring of histone deacetylases.

  2021cites this paper
• Design, synthesis, biochemical evaluation, radiolabeling and in vivo imaging with high affinity class-IIa histone deacetylase inhibitor for molecular imaging and targeted therapy

  2021cites this paper
• Metabolism in Huntington’s disease: a major contributor to pathology

  2021cites this paper
• Neurogenesis and Neuroprotection in Huntington Disease

  2021cites this paper
• An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases

  2021cites this paper
• A phosphoswitch at acinus-serine437 controls autophagic responses to cadmium exposure and neurodegenerative stress

  2021cites this paper
• α-Synuclein A53T Binds to Transcriptional Adapter 2-Alpha and Blocks Histone H3 Acetylation

  2021cites this paper
• Epigenetic regulation in Huntington's disease.

  2021cites this paper
• Activation of Cellular Antioxidant Defense System by Naturally Occurring Dibenzopyrone Derivatives Confers Neuroprotection against Oxidative Insults.

  2021cites this paper
• Decoding the role of coiled-coil motifs in human prion-like proteins

  2021cites this paper
• Modulation of Huntington's disease in Drosophila.

  2021cites this paper
• The S6k/4E-BP mediated growth promoting sub-pathway of insulin signalling cascade is essential to restrict pathogenesis of poly(Q) disorders in Drosophila.

  2021cites this paper
• Deciphering the key mechanisms leading to alteration of lipid metabolism in Drosophila model of Huntington's disease.

  2021cites this paper
• Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington’s disease mouse model

  2021cites this paper
• Structure, Activity and Function of the SETDB1 Protein Methyltransferase

  2021cites this paper
• The Role of Low Complexity Regions in Protein Interaction Modes: An Illustration in Huntingtin

  2021cites this paper
• The Effects of Selective Inhibition of Histone Deacetylase 1 and 3 in Huntington’s Disease Mice

  2021cites this paper